GRI Bio, Inc. - Common stock, par value $0.0001 per share (GRI)
CUSIP: 3622AW403
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common stock, par value $0.0001 per share
- Shares outstanding
- 10,989,570
- Total 13F shares
- 19,636
- Share change
- +14,786
- Total reported value
- $25,331
- Price per share
- $1.29
- Number of holders
- 5
- Value change
- +$19,075
- Number of buys
- 3
Quarterly Holders Quick Answers
What is CUSIP 3622AW403?
CUSIP 3622AW403 identifies GRI - GRI Bio, Inc. - Common stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 3622AW403:
Top shareholders of GRI - GRI Bio, Inc. - Common stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Albert Agro |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
172,189
|
$702,531 | — | 21 Apr 2023 | |
| Marella Thorell |
3/4/5
|
Director |
—
class O/S missing
|
9,506
|
$38,784 | — | 13 Dec 2022 | |
| Ofir Levi |
3/4/5
|
Director |
—
class O/S missing
|
30,000
|
$20,571 | — | 14 May 2021 | |
| Penny Toren |
3/4/5
|
SVP, Regul Affairs & Prog Mgmt |
—
class O/S missing
|
25,000
|
$17,143 | — | 14 May 2021 | |
| UBS Group AG |
13F
|
Company |
0.03%
|
3,245
|
$10,384 | — | 31 Mar 2025 | |
| Meenu Chhabra |
3/4/5
|
Director |
—
class O/S missing
|
15,000
|
$10,286 | — | 23 Feb 2022 | |
| Joseph E. Payne |
3/4/5
|
Director |
—
class O/S missing
|
7,500
|
$5,143 | — | 09 Jun 2022 | |
| Richard Ammer |
3/4/5
|
Director |
—
class O/S missing
|
7,500
|
$5,143 | — | 09 Jun 2022 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
1,273
|
$4,074 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0%
|
211
|
$675 | — | 31 Mar 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
117
|
$374 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
4
|
$13 | — | 31 Mar 2025 |
Institutional Holders of GRI Bio, Inc. - Common stock, par value $0.0001 per share (GRI) as of Q2 2025
As of 30 Jun 2025,
GRI Bio, Inc. - Common stock, par value $0.0001 per share (GRI) was held by
5 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
19,636 shares.
The largest 5 holders included
UBS Group AG, Tower Research Capital LLC (TRC), BlackRock, Inc., SBI Securities Co., Ltd., and BANK OF AMERICA CORP /DE/.
This page lists
5
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
5
Q2 2025 holders
5
Holder diff
0
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.